CTSO stock touches 52-week high at $1.6 amid robust annual growth
Cytosorbents Corporation (NASDAQ:CTSO) stock has reached a notable milestone, hitting a 52-week high of $1.6, signaling a ...
Hosted on MSN1mon
CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.
On January 3, 2025, CytoSorbents (NASDAQ:CTSO) reported strong preliminary 4th quarter and full year 2024 financial results which exceeded our expectations. 4 th quarter product revenue (excluding ...